Stealth BioTherapeutics Corp – NASDAQ:MITO

Stealth BioTherapeutics Corp stock price today

$0.32

Stealth BioTherapeutics Corp stock price monthly change

+1.59%
month

Stealth BioTherapeutics Corp stock price quarterly change

+2.89%
quarter

Stealth BioTherapeutics Corp stock price yearly change

-68.32%
year

Stealth BioTherapeutics Corp key metrics

Market Cap
N/A
Enterprise value
N/A
P/E
-0.34
EV/Sales
N/A
EV/EBITDA
0.01
Price/Sales
N/A
Price/Book
-0.36
PEG ratio
-0.06
EPS
-0.95
Revenue
N/A
EBITDA
-51.49M
Income
-54.28M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Stealth BioTherapeutics Corp stock price history

Stealth BioTherapeutics Corp stock forecast

Stealth BioTherapeutics Corp financial statements

Stealth BioTherapeutics Corp (NASDAQ:MITO): Profit margin
Jun 2021 0 -18.40M
Sep 2021 0 -6.29M
Dec 2021 0 -26.92M
Mar 2022 0 -2.65M
Stealth BioTherapeutics Corp (NASDAQ:MITO): Earnings per share (EPS)
2022-05-18 -0.02 -0.01
Stealth BioTherapeutics Corp (NASDAQ:MITO): Debt to assets
Jun 2021 32258000 58.57M 181.58%
Sep 2021 44187000 73.01M 165.25%
Dec 2021 50226000 95.52M 190.18%
Mar 2022 36915000 89.23M 241.72%
Stealth BioTherapeutics Corp (NASDAQ:MITO): Cash Flow
Jun 2020 0 0 0
Sep 2020 0 0 0
Dec 2020 -9.71M -20K 22.63M
Dec 2021 -35.25M 203K 36.50M

Stealth BioTherapeutics Corp alternative data

Stealth BioTherapeutics Corp (NASDAQ:MITO): Employee count
Aug 2023 38
Sep 2023 38
Oct 2023 38
Nov 2023 38
Dec 2023 38
Jan 2024 38
Feb 2024 38
Mar 2024 38
Apr 2024 38
May 2024 38
Jun 2024 38
Jul 2024 38

Stealth BioTherapeutics Corp other data

Patent
Grant
Filling date: 2 Dec 2019 Issue date: 8 Mar 2022
Application
Filling date: 19 Nov 2019 Issue date: 10 Feb 2022
Application
Filling date: 9 Jul 2021 Issue date: 30 Dec 2021
Application
Filling date: 16 Apr 2021 Issue date: 30 Dec 2021
Application
Filling date: 15 Jul 2019 Issue date: 28 Oct 2021
Application
Filling date: 2 Apr 2021 Issue date: 14 Oct 2021
Grant
Filling date: 17 Jan 2020 Issue date: 12 Oct 2021
Application
Filling date: 8 Apr 2021 Issue date: 23 Sep 2021
Grant
Filling date: 15 Jul 2020 Issue date: 10 Aug 2021
Grant
Filling date: 19 Jun 2017 Issue date: 10 Aug 2021
Tuesday, 7 May 2024
prnewswire.com
Monday, 6 May 2024
PRNewsWire
Wednesday, 8 June 2022
PennyStocks
Benzinga
Tuesday, 10 May 2022
PennyStocks
Monday, 2 May 2022
Benzinga
Wednesday, 9 March 2022
PRNewsWire
Tuesday, 22 February 2022
PRNewsWire
Tuesday, 4 January 2022
PRNewsWire
Thursday, 11 November 2021
Seeking Alpha
Wednesday, 20 October 2021
Benzinga
Thursday, 7 October 2021
PRNewsWire
Thursday, 23 September 2021
Benzinga
PRNewsWire
Wednesday, 15 September 2021
Pulse2
Tuesday, 14 September 2021
PRNewsWire
Tuesday, 7 September 2021
PRNewsWire
Wednesday, 25 August 2021
Zacks Investment Research
Tuesday, 24 August 2021
Benzinga
PRNewsWire
Monday, 23 August 2021
PRNewsWire
  • What's the price of Stealth BioTherapeutics Corp stock today?

    One share of Stealth BioTherapeutics Corp stock can currently be purchased for approximately $0.32.

  • When is Stealth BioTherapeutics Corp's next earnings date?

    Unfortunately, Stealth BioTherapeutics Corp's (MITO) next earnings date is currently unknown.

  • Does Stealth BioTherapeutics Corp pay dividends?

    No, Stealth BioTherapeutics Corp does not pay dividends.

  • What is Stealth BioTherapeutics Corp's stock symbol?

    Stealth BioTherapeutics Corp is traded on the NASDAQ under the ticker symbol "MITO".

  • What is Stealth BioTherapeutics Corp's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Stealth BioTherapeutics Corp?

    Shares of Stealth BioTherapeutics Corp can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Stealth BioTherapeutics Corp have?

    As Jul 2024, Stealth BioTherapeutics Corp employs 38 workers.

  • When Stealth BioTherapeutics Corp went public?

    Stealth BioTherapeutics Corp is publicly traded company for more then 6 years since IPO on 15 Feb 2019.

  • What is Stealth BioTherapeutics Corp's official website?

    The official website for Stealth BioTherapeutics Corp is stealthbt.com.

  • Where are Stealth BioTherapeutics Corp's headquarters?

    Stealth BioTherapeutics Corp is headquartered at 190 Elgin Avenue, George Town, GEORGE TOWN, GRAND CAYMAN.

  • How can i contact Stealth BioTherapeutics Corp?

    Stealth BioTherapeutics Corp's mailing address is 190 Elgin Avenue, George Town, GEORGE TOWN, GRAND CAYMAN and company can be reached via phone at +61 76006888.

Stealth BioTherapeutics Corp company profile:

Stealth BioTherapeutics Corp

stealthbt.com
Exchange:

NASDAQ

Full time employees:

38

Industry:

Biotechnology

Sector:

Healthcare

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands.

190 Elgin Avenue, George Town
GEORGE TOWN, GRAND CAYMAN KY1-9005

CIK: 0001696396
ISIN: US85789A1051
CUSIP: 85789A105